Antiphospholipid Antibodies Linked to Future CV Events

The study raises the possibility of one day treating the immune system in some individuals for the prevention and treatment of cardiovascular disease, researchers suggest.
Medscape Medical News

source https://www.medscape.com/viewarticle/990513?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension

RA and RA-ILD Linked to Higher Lung Cancer Risk

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?